JP Morgan Private Wealth Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-36,011
Closed -$263K 1397
2019
Q1
$263K Buy
36,011
+574
+2% +$5.61K ﹤0.01% 1271
2018
Q4
$324K Sell
35,437
-616
-2% -$6.82K ﹤0.01% 1132
2018
Q3
$447K Hold
36,053
﹤0.01% 1111
2018
Q2
$549K Buy
36,053
+616
+2% +$10.6K ﹤0.01% 977
2018
Q1
$703K Hold
35,437
﹤0.01% 761
2017
Q4
$663K Sell
35,437
-76,823
-68% -$1.54M ﹤0.01% 774
2017
Q3
$2.41M Buy
+112,260
New +$1.78M 0.02% 432

Other funds holding DVAX

JP Morgan Private Wealth Advisors's DVAX Position: Q2 2019 in Review

JP Morgan Private Wealth Advisors sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 36,011 shares — an estimated $263K sold.

JP Morgan Private Wealth Advisors first reported a position in DVAX in Q3 2017 and held it in 7 quarters. The position peaked at $2.41M in Q3 2017. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

  • JP Morgan Private Wealth Advisors reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 36,011 Dynavax Technologies shares in Q2 2019, an estimated $263K.
  • JP Morgan Private Wealth Advisors first reported a position in Dynavax Technologies in Q3 2017 and held it in 7 quarters.
  • JP Morgan Private Wealth Advisors's Dynavax Technologies position peaked at $2.41M in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.